Regulatives Submission Issues [Study As­sess­ment]

posted by balakotu – India, 2014-05-19 16:06 (4068 d 22:26 ago) – Posting: # 12970
Views: 4,942

Dear All,

Please clarify the below query

We conducted fed pivotal BE study. The clinical phase of study is initiated with 36 subjects as per protocol, out of 36 subjects only 17 Subjects completed the analysis. Whether we can submit the BE data with this less number of subjects (N=17 Subjects). Please share your thoughts on regulatory concerns in such cases of high dropouts.

Regards
Kotu.


Edit: Category changed. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,687 registered users;
61 visitors (0 registered, 61 guests [including 10 identified bots]).
Forum time: 14:33 CEST (Europe/Vienna)

If I’d observed all the rules,
I’d never have got anywhere.    Marilyn Monroe

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5